TG Therapeutics TGTX Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxAssetsNet.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's deferred tax assets?
- TG Therapeutics (TGTX) reported deferred tax assets of $344.14M in Q1 2026.
- What does deferred tax assets mean?
- Future tax benefits that the company expects to realize due to past losses or accounting differences.
- How do you interpret deferred tax assets?
- An increase often reflects accumulated losses, which can be valuable for offsetting future tax liabilities once the company becomes profitable.
- How does deferred tax assets compare across companies?
- High in pre-profit biotech companies due to significant R&D spending and accumulated tax loss carryforwards.